Ledger.Open graph →
SEC Form D · filed July 29, 2021

Endlyz Therapeutics, Inc

Offering
$6.5M
Sold
$3.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

John Gustofson · Boston, MADirectorJonathan Behr · Denver, CODirectorJoanna Wolak · Boston, MAExecDamian Crowther · Boston, MADirectorZaven Kaprielian · Boston, MAExec · DirectorJonathan Behr · Denver, CODirectorJoanna Wolak · Boston, MAExecJohn Gustofson · Boston, MADirectorDamian Crowther · Boston, MADirectorZaven Kaprielian · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗